期刊文献+

肝细胞癌合并肝硬化患者癌组织、癌旁肝组织ALB mRNA、IGF-1 mRNA、IGFBP-3 mRNA的表达

EXPRESSION OF ALB mRNA,IGF-1 mRNA,IGFBP-3 mRNA IN TUMOR TISSUES AND ADJACENT NON-TUMOR TISSUES OF HEPATOCELLULAR CARCINOMA PATIENTS WITH CIRRHOSIS
下载PDF
导出
摘要 目的探讨肝细胞癌合并肝硬化患者癌组织、癌旁肝组织ALB mRNA、IGF-1mRNA、IGFBP-3mRNA的表达。方法对24例肝细胞癌合并肝硬化行手术的患者和12例因胆石症或肝血管瘤行手术的患者进行研究。用RT-PCR法检测肝组织(包括癌组织、癌旁组织)ALBmRNA、IGF-1mRNA、IGFBP-3mRNA的表达,肝组织行Ki67免疫组织化染色。结果肝细胞癌合并肝硬化患者癌组织、癌旁肝组织ALB mRNA、IGF-1mRNA、IGFBP-3mRNA表达水平明显低于正常肝组织,且癌组织ALB mRNA、IGFBP-3mR-NA表达水平明显低于癌旁肝组织,而IGF-1mRNA表达水平明显高于癌旁肝组织。肝组织Ki67指数,癌组织、癌旁肝组织明显高于正常肝组织,且癌组织明显高于癌旁肝组织。结论IGF-1和IGFBP-3的不平衡可能与肝硬化患者肝癌的发生、发展有关。 Objective To explore the expression of ALB mRNA,IGF - 1 mRNA, IGFBP - 3 mRNA in tumor tissues and adjacent non - tumor tissues of hepatoeellular carcinoma (HCC) patients with cirrhosis. Methods 24 patients with hepatoeelluiar carcinoma patients with cirrhosis who underwent hepateetomy were studied. ALB mRNA ,IGF -1 mRNA and IGFBP- 3 mRNA in liver (including tumor tissues and adjacent nontumor tissues) were detected by RT - PCR. Liver Ki67 immunokistoehemistry staining was studied. At the same time, 12 patients with cholelithiasis or liver angioma who underwent operation severed as normal control. Results In HCC patients with cirrhosis,hepatic ALB mRNA, IGF - 1 mRNA, IGFBP - 3 mRNA of tumor tissues or adjacent non - tumor tissues were more lower than the normal liver tissues, while in tumor tissues, hepatic ALB mRNA, IGFBP -3 mRNA were more lower, hepatic IGF - 1 mRNA was more higher than in adjacent non - tumor tissues. Liver Ki67 labeling index in tumor tissues or adjacent non - tumor tissues were more higher than the normal liver tissues ,while tumor tissues was more higher than adjacent non - tumor tissues. Conclusion Imbalance of IGF - land IGFBP - 3 may be associated with hepatoeareinogenesis and tumour development of liver cirrhosis patients.
出处 《现代医院》 2010年第4期16-18,共3页 Modern Hospitals
基金 广东省科技计划项目(编号:2007B031515001)
关键词 肝细胞癌 胰岛素样生长因子-1 胰岛素样生长因子结合蛋白-3 Hepatocellular carcinoma, Insulin growth factor - 1, Insulin like growth factor binding protein - 3
  • 相关文献

参考文献7

  • 1SCHARF JG,SCHMITZ F,FRYSTYK J,et al.Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease[J].J Hepatol,1996,25(5):689-699.
  • 2陈照丽,王欣,黄秉仁.IGF系统的生物学功能及其与肿瘤的关系[J].国外医学(分子生物学分册),2003,25(1):34-37. 被引量:27
  • 3JEROME L,SHIRY L,LEYLAND-JONES B.Deregulation of the IGF axis in cancer:epidemiological evidence and potential therapeutic interventions[J].Endocr Relat Cancer,2003,10(4):561-578.
  • 4MOSCHOS SJ,MANTZOROS CS.The role of the IGF system in cancer:from basic to clinical studies and clinical applications[J].Oncology,2002,63(4):317-332.
  • 5HANAFUSA T,YUMOTO Y,NOUSO K,et al.Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma[J].Cancer Lett,2002,176(2):149-158.
  • 6HUYNH H,CHOW PK,OOI LL,et al.A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation[J].Cell Growth Differ,2002,13(3):115-122.
  • 7AIHARA T,NOGUCHI S,MIYOSHI Y,et al.Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver[J].Hepatology,1998,28(1):86-89.

二级参考文献16

  • 1[1]Eckhard Wolf et al. Growth Horm IGF Res,1998;8:185
  • 2[2]Valentinis B et al. J Biol Chem,1999;274:12423
  • 3[3]Gampbell PG et al.J Biol Chem,1999;274(42):30215
  • 4[4]Zumkeller W et al. Mol Pathol,2001;54(4):227
  • 5[5]Valentinis B et al. Mol Pathol,2001;54(3):133
  • 6[6]Blakesley VA et al. J Biol Chem,1998;273:18411
  • 7[7]Chen H et al .Cell Growth Differ,1998;9:939
  • 8[8]Dupont J et al. Mol Pathol,2001;54(3):149
  • 9[9]Vella V et al. Mol Pathol,2001;54(3):121
  • 10[10]Weber MM et al. Eur J Clin Invest,2000;30 Suppl 3:69

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部